Gene Therapy Initiative
- Mission
- Impact
- Leadership
- Board
- Seed Grant
- Symposium
- Support
- Contact
- News Archive
Three of our GTI leaders, Chamindra Laverty, Alysson Muotri, and Stephanie Cherqui, presented at the 27th Annual American Society for Gene and Cell Therapy in Baltimore Maryland this May. Topics covered lessons about clinical efficacy and safety of AAV gene therapy, brain organoid applications in gene therapy, and the bench- to- bedside- to- bench feedback loop that advances ex vivo gene therapy.
GTI Director of Research Engagement, Betty Cabrera, was a panel member for a RARE Drug Development Symposium session in Philadelphia focused on emerging commercial and non-profit financing models of preclinical drug development. GTI highlighted how UCSD investigators are demonstrating that rare disease research can lead to applications to more common diseases.